TransMedics Group, Inc. Operating Income Loss

• TransMedics Group, Inc. showed an increase of +189.6% in Operating Income Loss from 2024 to 2025.
• This data is from TransMedics Group, Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
• XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2018 to 2025), TransMedics Group, Inc.'s Operating Income Loss has grown by 636.6%.
• Historical annual values: Fiscal year 2025: $108.58 million | Fiscal year 2024: $37.50 million | Fiscal year 2023: -$28.73 million | Fiscal year 2022: -$31.44 million | Fiscal year 2021: -$39.43 million | Fiscal year 2020: -$26.38 million | Fiscal year 2019: -$29.60 million | Fiscal year 2018: -$20.24 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026